Disc Medicine (NASDAQ:IRON) Coverage Initiated by Analysts at Raymond James
Raymond James assumed coverage on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a research note published on Wednesday morning, MarketBeat.com reports. The brokerage issued a strong-buy rating and a $89.00 price target on the stock. A number of other research firms have also issued reports on IRON. Scotiabank raised their price target on […]
Raymond James assumed coverage on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a research note published on Wednesday morning, MarketBeat.com reports. The brokerage issued a strong-buy rating and a $89.00 price target on the stock. A number of other research firms have also issued reports on IRON. Scotiabank raised their price target on […]
